title: Hormone replacement therapy: reassessing the risks and benefits.
abstract: Although the association between postmenopausal hormone use and breast cancer has not been clarified, there is nothing indefinite about the survival advantage conferred by hormone replacement therapy. Cardiovascular and fracture-related deaths so outnumber breast cancer deaths that even women with family histories of the latter are likely to benefit from low-potency estrogen replacement.
authors.affiliation: University of Southern California School of Medicine, Los Angeles, USA.
authors.forename: D
authors.initials: D
authors.lastname: Shoupe
mesh_terms: D000075202:Contraindications; D045166:Estradiol Congeners / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D008875:Middle Aged; D009026:Mortality / Q000639:trends; D017698:Postmenopause / Q000187:drug effects; D012307:Risk Factors; D045165:Testosterone Congeners / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D045166:Estradiol Congeners; D045165:Testosterone Congeners